A
Avalo Therapeutics, Inc.
AVTX · NASDAQ · Healthcare · 1.0B
Closing price
$13.65
+1.64% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.2×
Enterprise value / EBITDAEV/EBITDA
-2.2×
Free cash flow yieldFCF yield
-28.1%
Return on equityROE
-94.2%
Operating margin
-123601.7%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.